Abstract:Background: Kirsten rat sarcoma (KRAS) mutation drives resistance to anti-epidermal growth factor receptor (anti-EGFR)-targeted therapies in rectal cancer. Amide proton transfer-weighted magnetic resonance imaging (APTw MRI) might be a supplement to the evaluation of KRAS mutation because the APTw value can reflect mobile cellular protein content in vivo. This study aimed to determine whether APTw MRI could predict KRAS mutation in rectal cancer and compare this technique with diffusion-weighted imaging (DWI). Methods: This retrospective study reviewed 153 consecutive patients with rectal cancer from April 2019 to June 2021 in our hospital. Among them, a total of 55 patients who did not undergo neoadjuvant chemoradiotherapy and underwent preoperative APTw MRI, DWI, and postoperative KRAS tests were included in this study. In two-dimensional APTw images, two radiologists manually delineated three regions of interest (ROIs) along tumor contour in the largest slice and the adjacent two slices of tumor respectively. The mean APTw value within a ROI was calculated, and the values of three ROIs were averaged for each patient. In consecutive DWI images, two radiologists depicted the ROIs of the whole lesion, and the mean apparent diffusion coefficient (ADC) was generated. The intraclass correlation coefficient (ICC), Shapiro-Wilk test and Student's t-test were used for statistical analyses. Receiver operating characteristic (ROC) curves were constructed for APTw and ADC values respectively, and the area under the curve (AUC) was used to evaluate the diagnostic performance for the prediction of KRAS mutation. Results: Among these 55 patients, KRAS mutation occurred in 21 patients. The ICCs of two independent raters for APTw and ADC values were 0.937 [95% confidence interval (CI), 0.914-0.953] and 0.976 (95% CI, 0.959-0.986), respectively. ADC values did not show a statistically significant difference between the KRAS-mutant group and the wild type (WT) group (P=0.733). KRAS-mutant tumors exhibited a higher APTw value than WT tumors in patients with rectal non-mucinous adenocarcinoma (3.324%±0.685% vs. 2.230%±0.833%, P<0.001). The AUC of the APTw value was 0.827 (95% CI, 0.701-0.916), with a cutoff value of 2.4% (sensitivity, 95.2%; specificity, 55.9%). Conclusions: DWI cannot differentiate mutant KRAS genes from WT genes in patients with rectal cancer, but APTw MRI has potential for evaluating KRAS mutation in rectal cancer. The APTw value had moderate diagnostic performance in the prediction of KRAS mutation with a high sensitivity but a low specificity. APTw MRI might be a promising supplement to KRAS genomic analysis in rectal cancer patients.

Assessment of prognostic indicators and KRAS mutations in rectal cancer using a fractional-order calculus MR diffusion model: whole tumor histogram analysis

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.

Utilization of diffusion-weighted derived mathematical models to predict prognostic factors of resectable rectal cancer

Pathological prognostic factors of rectal cancer based on diffusion-weighted imaging, intravoxel incoherent motion, and diffusion kurtosis imaging

Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: A prospective single-center study.

SU-D-BRA-04: Fractal Dimension Analysis of Edge-Detected Rectal Cancer CTs for Outcome Prediction

The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging.

Comparison of diffusion-weighted imaging and pathological prognostic factors in rectal cancer

Diffusion kurtosis imaging and MRI-detected extramural venous invasion in rectal cancer: correlation with clinicopathological prognostic factors

Predictive value of mono-exponential and multiple mathematical models in locally advanced rectal cancer response to neoadjuvant chemoradiotherapy

Value of non-Gaussian diffusion imaging with a fractional order calculus model combined with conventional MRI for differentiating histological types of cervical cancer

Characterization of rectal cancer: Whole-tumour histogram analysis of diffusion kurtosis imaging at 3 T

Restriction Spectrum Imaging and Diffusion Kurtosis Imaging for Assessing Proliferation Status in Rectal Carcinoma

Diffusion kurtosis imaging in the characterisation of rectal cancer: utilizing the most repeatable region-of-interest strategy for diffusion parameters on a 3T scanner

Non‐Gaussian Diffusion Imaging with a Fractional Order Calculus Model to Predict Response of Gastrointestinal Stromal Tumor to Second‐line Sunitinib Therapy

In vivo assessment of Lauren classification for gastric adenocarcinoma using diffusion MRI with a fractional order calculus model

Differentiation of Low- and High-Grade Pediatric Brain Tumors with Highb-Value Diffusion-weighted MR Imaging and a Fractional Order Calculus Model

Diffusion-weighted Magnetic Resonance Imaging for Predicting the Response of Rectal Cancer to Neoadjuvant Concurrent Chemoradiation

Diffusion Parameters of Rectal Cancer Derived from Diffusion Kurtosis Imaging (DKI): Effect of Slice Protocols and Region of Interest on Measurement Consistency of Parameters

Prediction of Kirsten rat sarcoma (KRAS) mutation in rectal cancer with amide proton transfer-weighted magnetic resonance imaging

A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Evaluation of KRAS Mutation in Rectal Cancer